We are live on ! Find out more
SCM

Suvretta Capital Management Portfolio holdings

AUM $3.92B
1-Year Est. Return 86.67%
This Fund
S&P 500
This Quarter Est. Return
+5.04%
1 Year Est. Return
+86.67%
3 Year Est. Return
+295.96%
5 Year Est. Return
+364.48%
10 Year Est. Return
+2,073.65%
AUM
$5.16B
AUM Growth
-$770M
Cap. Flow
-$830M
Cap. Flow %
-16.07%
Top 10 Hldgs %
43.16%
Holding
126
New
20
Increased
28
Reduced
23
Closed
31

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$280M
2
MNST icon
Monster Beverage
MNST
+$102M
3
HLT icon
Hilton Worldwide
HLT
+$86.3M
4
DECK icon
Deckers Outdoor
DECK
+$83.7M
5
MAR icon
Marriott International
MAR
+$77.7M

Top Sells

Rank Stock Value
1
TWLO icon
Twilio
TWLO
+$165M
2
ADBE icon
Adobe
ADBE
+$152M
3
MA icon
Mastercard
MA
+$147M
4
PLAN
Anaplan, Inc.
PLAN
+$132M
5
ROST icon
Ross Stores
ROST
+$122M

Sector Composition

Rank Sector Weight
1 Healthcare 35.24%
2 Consumer Discretionary 21.52%
3 Technology 17.66%
4 Industrials 15.63%
5 Consumer Staples 5.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NUVL
76
DELISTED
Nuvalent
NUVL
$3.81M 0.07%
200,000
– –
IMRX icon
77
Immuneering
IMRX
$292M
$3.23M 0.06%
200,000
– –
OMEG
78
DELISTED
Omega Alpha SPAC Class A Ordinary Shares
OMEG
$2.93M 0.06%
300,000
– –
EBAC
79
DELISTED
European Biotech Acquisition Corp. Class A Ordinary Shares
EBAC
$2.91M 0.06%
300,000
– –
BNTC icon
80
Benitec Biopharma
BNTC
$468M
$2.02M 0.04%
45,235
– –
OHAAU
81
DELISTED
OPY Acquisition Corp. I Units
OHAAU
$2M 0.04%
+200,000
New +$2M
TMPM
82
DELISTED
Turmeric Acquisition Corp. Class A Ordinary Shares
TMPM
$1.96M 0.04%
200,000
– –
BLSA
83
DELISTED
BCLS Acquisition Corp. Class A Ordinary Shares
BLSA
$1.96M 0.04%
200,000
– –
TRDA icon
84
Entrada Therapeutics
TRDA
$267M
$1.81M 0.04%
+106,000
New +$2.57M
CANO.WS
85
DELISTED
Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150
CANO.WS
$1.61M 0.03%
674,566
– –
DBTX
86
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
$1.23M 0.02%
263,600
– –
EUCR
87
DELISTED
Eucrates Biomedical Acquisition Corp. Ordinary Shares
EUCR
$976K 0.02%
99,999
– –
FLAC
88
DELISTED
Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares
FLAC
$853K 0.02%
87,498
– –
MGTX icon
89
MeiraGTx Holdings
MGTX
$1.21B
$821K 0.02%
+34,600
New +$662K
SRNE
90
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$492K 0.01%
+105,744
New +$656K
FSRXW
91
DELISTED
FinServ Acquisition Corp. II Warrant
FSRXW
$169K ﹤0.01%
273,149
– –
EBACW
92
DELISTED
European Biotech Acquisition Corp. Warrant
EBACW
$60K ﹤0.01%
100,000
– –
TMPMW
93
DELISTED
Turmeric Acquisition Corp. Warrant
TMPMW
$45K ﹤0.01%
66,666
– –
EUCRW
94
DELISTED
Eucrates Biomedical Acquisition Corp. Warrant
EUCRW
$19K ﹤0.01%
33,333
– –
FLACW
95
DELISTED
Frazier Lifesciences Acquisition Corporation Warrant
FLACW
$17K ﹤0.01%
29,166
– –
ACHR icon
96
Archer Aviation
ACHR
$4.26B
– –
-750,000
Closed -$6.66M
ACIU icon
97
AC Immune
ACIU
$240M
– –
-963,500
Closed -$6.46M
ADAG
98
Adagene
ADAG
$272M
– –
-42,722
Closed -$614K
BCAB icon
99
BioAtla
BCAB
$5.74M
– –
-7,084
Closed -$10.4M
ESTC icon
100
Elastic
ESTC
$7.81B
– –
-271,000
Closed -$40.4M
2 3
4
5 6

Similar funds

MIM
Meridiem Investment Management London, United Kingdom $3.92B AUM 1.64% 1-Year Est. Return
BCP
BSN Capital Partners London, United Kingdom $3.93B AUM 13.09% 1-Year Est. Return
AS
American Securities New York $3.93B AUM 52.22% 1-Year Est. Return
MSI
Mitsui Sumitomo Insurance Tokyo, Japan $3.9B AUM
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
LWCA
Locust Wood Capital Advisers New York $3.95B AUM 33.1% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
USCWA
U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return

Suvretta Capital Management's Q4 2021 Portfolio in Review

As of Q4 2021, Suvretta Capital Management held 126 positions worth $5.16B, down 13% from $5.94B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Suvretta Capital Management withdrew a net $830M in Q4 2021, closing 31 positions and reducing 23 holdings. Its most notable exit was Twilio, an estimated $165M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 32% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, Suvretta Capital Management opened a new position in Microsoft worth $291M.

  • Suvretta Capital Management's largest Q4 2021 buy was Microsoft: 865,000 shares worth $291M.
  • Suvretta Capital Management added most to Analog Devices in Q4 2021, an estimated $60.5M increase.
  • Suvretta Capital Management's biggest Q4 2021 reduction was Adobe, cutting an estimated $152M.
  • Suvretta Capital Management fully exited Twilio in Q4 2021, selling an estimated $165M.
  • Suvretta Capital Management's ten largest holdings make up 43% of its $5.16B portfolio in Q4 2021.
  • Suvretta Capital Management opened 20 new positions and closed 31 in Q4 2021.
  • Suvretta Capital Management's portfolio value fell 13% quarter-over-quarter to $5.16B.

Based on Suvretta Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.